Thank you. An attorney from our network will call you within 15 minutes to discuss your Depo-Provera case at no cost to you.
The litigation is already one of the 25 largest in the nation — and growing fast. Here's what's at stake.
Active Depo-Provera lawsuits filed in federal court as of May 2026 — and new cases added every week
Increased risk of meningioma in long-term Depo-Provera users confirmed by a 10-million-woman Cleveland Clinic study (JAMA Neurology, Sept 2025)
Projected individual settlement range based on injury severity, medical costs, and quality-of-life impact
FDA officially added a meningioma brain-tumor warning to Depo-Provera labels — weakening Pfizer's key defense
Federal multidistrict litigation established in the Northern District of Florida under Judge M. Casey Rodgers
First bellwether trials expected to begin — strong verdicts will accelerate settlement talks with Pfizer
Simple 3-Step Process
Deadlines vary by state. Don't wait — it's free and there's no obligation.
Pfizer has been facing mass litigation, but deadlines vary by state. Complete the form today to protect your rights and secure the best chance at the compensation you deserve.
Our team will contact you within 15 minutes to discuss your options and gather the information needed to pursue your claim. Completely free — no obligation whatsoever.
Your attorney will fight for the best possible compensation. There are zero up-front costs — your attorney only gets paid when a settlement or verdict is won for your case.
The Science & The Cover-Up
Science linking Depo-Provera to meningioma dates back to 1983. Women deserved to know.
A landmark study published in JAMA Neurology (September 2025) analyzed more than 10 million women across 68 health systems and confirmed a 2.43 relative risk of meningioma in long-term Depo-Provera users. No other contraceptive studied showed comparable danger.
This was not the first red flag. In 1983, a study in the European Journal of Cancer identified a high concentration of progesterone receptors in meningioma tissue — suggesting hormonal contraceptives could feed tumor growth. Pfizer and its predecessors had decades to act and chose not to warn patients.
The FDA finally required a meningioma warning on Depo-Provera labels in December 2025 — but millions of women who used the drug before that date received no warning of any kind. If you're one of them, the law is on your side.
Used Depo-Provera and were later diagnosed with a meningioma or brain tumor — regardless of how long ago.
Do I Qualify? Find Out Free →Case Timeline
Staying informed is critical. Here is where things stand as of May 2026.